Clinical Trials in Phoenix

Showing 11841-11860 of 16,646 trials

A Study in Type 2 Diabetics of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics

NCT01119846

The purpose of this study is to see if GSK1292263 is safe and well-tolerated when administered to type 2 diabetics, and to get preliminary information about whether it may be effective in the treatment of type 2 diabetes.

Diabetes Mellitus, Type 2

GlaxoSmithKline100 participantsStarted Jun 2009

Phoenix, Arizona, United States • Chula Vista, California, United States • Miami, Florida, United States +4 more locations

COMPLETEDPhase 2< 1 mile

The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term Labor

NCT00404768

Pre-Term Labor (prior to 37 weeks gestation) is the largest single cause of infant morbidity and mortality and is frequently associated with long-term disability. Oxytocin is a hormone produced by the body during labor. GSK221149A is an experimental drug that will be used to block the effects of oxytocin, and therefore pause or prevent contractions. In this study, patients with preterm labor will be given an intravenous infusion of GSK221149A over approximately 12 hours followed by an oral tablet in Parts A and B. In part C of this study, patients with preterm labor will be give an intravenous infusion of GSK221149A over approximately 48 hours. The use of a rescue tocolytic is allowed in the study.

Obstetric Labour, Premature

GlaxoSmithKline93 participantsStarted Oct 2007

Mobile, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +54 more locations

A Study in Type 2 Diabetics of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics

The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term Labor

Find Trials by Condition in Phoenix

Phase II Study of the Safety and Efficacy of the Relay Thoracic Stent-Graft

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma

A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects

EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Multi-site Validation and Application of a Consensus DSC-MRI Protocol

Epigenetics and the Origin of Muscle Insulin Resistance in Humans

Study Evaluating the Safety and Tolerability of Weekly Dosing of Oral IXAZOMIB in Adult Patients With Relapsed and Refractory Multiple Myeloma

Alendronate to Prevent Loss of Bronchoprotection in Asthma

Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT)

A Study of the Trabecular Micro-bypass Stent in Combination With Cataract Surgery in Subjects With Open Angle Glaucoma

3-year Follow-up Study to Assess the Viral Activity in Hepatitis C Patients Who Failed Feeder DEB025/Alisporivir Study

Smartphone Ophthalmoscope of Lens Vascularity to Estimate Gestational Age

An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis

Dolutegravir Compared to Darunavir/Ritonavir , Each in Combination With Dual Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in ART-naive Subjects

Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS)

Safety and Efficacy of OsmoPrep® Tablets Versus HalfLytely® and Bisacodyl Tablet Bowel Prep Kit for Colon Cleansing

OSI-774 (Tarceva) in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer